Brief: Chimeric Therapeutics Announces A$4.0 Million Non-Dilutionary Funding
27/02/2025 07:03
Feb 27 (Reuters) - Chimeric Therapeutics Ltd CHM.AX: US-BASED FAMILY OFFICE PROVIDES A$4.0 MILLION NON-DILUTIONARY FUNDING FOR DEVELOPMENT OF CHM CDH17 CAR-T Further company coverage: CHM.AX ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Chimeric Therapeutics
See all newsBrief: Chimeric Therapeutics Says Phillip Hains Appointed Interim Chairman
Brief: Chimeric Therapeutics Posts Prelim Loss For Year Of A$18.8 MLN
Brief: Chimeric Therapeutics Intends To Enter Negotiations With Its Creditors
Brief: Chimeric Therapeutics Seeks Trading Halt
Australia's Chimeric Therapeutics rises on positive data for its cell therapy clinical trial